Other Headlines
Have News for Us?
Submit your news on the industry, people, or companies.
Forward to a FriendMore People & Company Headlines
Ceremony and Fund for Families of MedEvac Helicopter Crash The medical community pays tribute to a dedicated crew.
Interview with Beth Bukata, Assistant Director of Communications for ASTRO DOTmed discusses the American Society for Therapeutic Radiation Oncology (ASTRO) program for public awareness with ASTRO's assistant director of communications, Beth Bukata.
Ingestible Device Monitors GI Tract on the Go GI monitoring device promises to speed the evaluation and treatment of GI motility disorders.
iBrain Could Predict Drug Side Effects by Measuring Brainwaves A cell phone sized gadget could help predict drug side effects while even saying who's your twin -- just by recording brainwaves during sleep. Welcome to iBrain.
Nationwide Opens New Service Division Nationwide Imaging Services is now operating a new servicing and installation division, Nationwide Medical Equipment Services, LLC.
Stryker to Spend Almost $100 Million in New Acquisitions Stryker picks up Calif. software company OtisMed, and acquires assets behind Sonopet's ultrasonic aspirators.
The "Ratings Push" Is on That Will Choose The DOTmed 100 for 2010 -- The DOTmed 100 is a peer-evaluation program, so it's one of the truest measures of a company's commitment to integrity and customer satisfaction
Pacific Medical, LLC Expands Their Repair Facility Satisfied biomed customers and continued growth led to the move.
Genesis Magnet Services Celebrates Ten Years in Business A decade of MR quality from the independent service organization.
How Will Medicare Reform Impact Providers? A DOTmed Business News columnist comments on CMS and reform issues.
Mentor Corporation
Johnson & Johnson Announces Agreement to Buy Mentor Corp.
Under the terms of the agreement, J&J will purchase all outstanding shares of Mentor at $31.00 per share, a premium of $14.85, or 92 percent, over Mentor's closing price last Friday of $16.15. After announcing the purchase, Mentor's stock leapt 90 percent to $30.71. J&J's stock fell 2.7 percent to $57.03.
This is the second acquisition J&J has announced in the last week. In November, J&J said it would acquire biotech company Omrix Biopharmacueticals Inc. for $438 million to grow its surgical care business. Now that many biotech and healthcare companies are at market lows, Wall Street expects the company to ink more deals in the near future.
Mentor is expected to operate as a stand-alone business unit reporting through Ethicon, Inc., J&J's subsidiary that is a leading provider of suture, mesh and other surgical products.
Upon closing, the transaction is expected to have a dilutive impact to Johnson & Johnson's 2009 earnings per share of approximately $.03-$.05. The merger is expected to close in the first quarter of 2009.
Interested in Medical Industry News?
Subscribe to DOTmed's weekly news email and always be informed.
Click here, it takes just 30 seconds.
|
Please Send us your Comments. |
|
|
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2009 DOTmed.com, Inc.
ALL RIGHTS RESERVED
